Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TEMOZOLOMIDE for Neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 45 adverse event reports in the FDA FAERS database where TEMOZOLOMIDE was used for Neoplasm.

Most Reported Side Effects for TEMOZOLOMIDE

Side Effect Reports % Deaths Hosp.
Disease progression 1,562 9.2% 384 194
Death 1,403 8.3% 1,361 69
Off label use 1,357 8.0% 196 184
Product use in unapproved indication 1,353 8.0% 82 80
Thrombocytopenia 1,300 7.6% 236 410
Drug ineffective 1,131 6.7% 275 206
Nausea 1,071 6.3% 84 309
Neutropenia 809 4.8% 149 211
Malignant neoplasm progression 779 4.6% 208 125
Fatigue 766 4.5% 80 190
Vomiting 697 4.1% 84 272
Febrile neutropenia 616 3.6% 47 186
Anaemia 592 3.5% 75 113
Seizure 537 3.2% 63 320
Diarrhoea 469 2.8% 56 188

Other Indications for TEMOZOLOMIDE

Glioblastoma (2,346) Brain neoplasm malignant (2,202) Glioblastoma multiforme (868) Product used for unknown indication (781) Glioma (502) Central nervous system lymphoma (402) Brain neoplasm (286) Anaplastic astrocytoma (282) Chemotherapy (262) Neuroendocrine tumour (252)

Other Drugs Used for Neoplasm

BEVACIZUMAB (502) ATEZOLIZUMAB (404) CYCLOPHOSPHAMIDE (385) CARBOPLATIN (283) PACLITAXEL (267) NIVOLUMAB (219) OXALIPLATIN (185) PEMBROLIZUMAB (173) LENALIDOMIDE (171) DOXORUBICIN (150)

Related Pages

TEMOZOLOMIDE Full Profile All Neoplasm Drugs TEMOZOLOMIDE Demographics TEMOZOLOMIDE Timeline